Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
111in-dota-h11b6 (1 trial)
Neoplasm Metastasis (Phase 1)
Prostatic Neoplasms (Phase 1)
Prostatic Neoplasms, Castration-Resistant (Phase 1)
Trials (1 total)
Trial APIs (1 total)